Brent Wilkinson
Family Medicine · Union Gap, WANPI 1891319448
Payments from drug & device makers
Across 198 payments — averaging $17.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$570
- AbbVie$452
- Pfizer$441
- Takeda Pharmaceuticals U.S.A., Inc.$264
- Novo Nordisk$255
- Boehringer Ingelheim$237
- plus $1K from 22 others
What the payments were for
- Food & beverage$3,525100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca(2 entities) | 23 | $570 |
| AbbVie | 28 | $452 |
| Pfizer | 41 | $441 |
| Takeda Pharmaceuticals U.S.A., Inc. | 11 | $264 |
| Novo Nordisk | 18 | $255 |
| Boehringer Ingelheim | 10 | $237 |
| Corcept Therapeutics | 11 | $155 |
| Daiichi Sankyo Inc. | 5 | $117 |
| Novartis | 4 | $109 |
| Xeris Pharmaceuticals, Inc. | 5 | $106 |
| GSK | 6 | $105 |
| Lundbeck LLC | 6 | $98 |
| Exact Sciences | 4 | $94 |
| Amgen | 4 | $66 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $49 |
| Sumitomo Pharma America, Inc. | 2 | $49 |
| Astellas Pharma US Inc | 2 | $44 |
| Sanofi-aventis U.S. LLC | 2 | $39 |
| Chiesi USA, Inc. | 2 | $36 |
| Johnson & Johnson | 1 | $35 |
| Lilly USA, LLC | 2 | $35 |
| Viiv Healthcare Company | 1 | $32 |
| Abbott | 1 | $31 |
| Bayer | 2 | $28 |
| Otsuka America Pharmaceutical, Inc. | 1 | $22 |
| Ascensia Diabetes Care US Inc. | 1 | $22 |
| Phathom Pharmaceuticals, Inc. | 2 | $18 |
| Supernus Pharmaceuticals, Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,525 in reported general payments places this provider in the 90th percentile of 2,275 family medicine providers in Washington.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| FarxigaDapagliflozin Propanediol | 106 | $93,437 |
| Dupixent SyringeDupilumab | 13 | $56,976 |
| EliquisApixaban | 35 | $36,064 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 44 | $31,460 |
| OzempicSemaglutide | 28 | $29,029 |
| JardianceEmpagliflozin | 32 | $26,763 |
| XareltoRivaroxaban | 27 | $25,831 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 27 | $20,386 |
| TrulicityDulaglutide | 11 | $17,221 |
| EntrestoSacubitril/Valsartan | 12 | $9,852 |
| TradjentaLinagliptin | 12 | $7,576 |
| DapagliflozinDapagliflozin Propanediol | 13 | $6,806 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 46 | $3,840 |
| Gabapentin | 159 | $2,639 |
| Insulin Lispro Kwikpen U-100Insulin Lispro | 23 | $2,588 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AstraZenecaFarxiga, Breztri Aerosphere | $570 | $113,822133 claims |
| PfizerEliquis | $441 | $36,06435 claims |
| Boehringer IngelheimJardiance, Tradjenta | $237 | $34,33944 claims |
| GSKTrelegy Ellipta | $105 | $31,46044 claims |
| Novo NordiskOzempic, Levemir | $255 | $30,56741 claims |
| Johnson & JohnsonXarelto | $35 | $25,83127 claims |
| Lilly USA, LLCTrulicity | $35 | $17,22111 claims |
| NovartisEntresto | $109 | $9,85212 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 2,275 family medicine providers in Washington.
Other family medicine in Union Gap
- Charles BulfinchUnion Gap$16K
- Anton GraschWenatchee$5.3M
- Gaylon KippBellevue$4.8M
- Steven KasterWenatchee$4M
- Angela EakinSpokane$3M
- Jonathan StabenCheney$2.5M
- Emily ZaragozaSeattle$1.9M
- Brad FrandsenPort Orchard$1.7M
- Kevin HatfieldSeattle$527K
- Steven SmithAuburn$438K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.